Systematic review and meta-analysis on the role of mitochondrial cytochrome c oxidase in Alzheimer's disease.
Acta Neuropsychiatr
; 33(2): 55-64, 2021 Apr.
Article
en En
| MEDLINE
| ID: mdl-33256871
ABSTRACT
OBJECTIVE:
The present study was designed to test the hypothesis that there is a reduction in the activity of the enzyme cytochrome c oxidase (Cox) in Alzheimer's disease (AD).METHODS:
Systematic review of literature and meta-analysis were used with data obtained from the PubMed, Scopus, MEDLINE, Lilacs, Eric and Cochrane. The keywords were Alzheimer's AND Cox AND mitochondria; Alzheimer's AND Cox AND mitochondria; Alzheimer's AND complex IV AND mitochondria. A total of 1372 articles were found, 23 of them fitting the inclusion criteria. The data were assembled in an Excel spreadsheet and analysed using the RevMan software. A random effects model was adopted to the estimative of the effect.RESULTS:
The data shows a significant decrease in the activity of the Cox AD patients and animal models.CONCLUSION:
Cox enzyme may be an important molecular component involved in the mechanisms underlying AD. Therefore, this enzyme may represent a possible new biomarker for the disease as a complementary diagnosis and a new treatment target for AD.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Complejo IV de Transporte de Electrones
/
Enfermedad de Alzheimer
/
Mitocondrias
Tipo de estudio:
Diagnostic_studies
/
Prognostic_studies
/
Systematic_reviews
Límite:
Animals
/
Humans
Idioma:
En
Revista:
Acta Neuropsychiatr
Año:
2021
Tipo del documento:
Article
País de afiliación:
Brasil